SUMMARY
Introduction:
Indiscriminate use of red blood cell concentrate transfusions can have adverse effects, so it is important to understand the trends in each hospital unit in order to implement and standardize criteria for transfusion indications and improve the quality of this therapeutic measure.
Objective:
To identify the hemoglobin and hematocrit values and diagnoses associated with red blood cell concentrate transfusion in a neonatal intensive care unit (NICU).
Materials and methods:
An observational, retrospective, analytical, and cross-sectional study was conducted in the NICU of the General Hospital of Zone No. 1 Nueva Frontera in Tapachula, Chiapas, by reviewing patient records from January 2021 to December 2023.
Results:
A total of 115 patients were evaluated. The mean hemoglobin level was 11.5 g/dL and the mean hematocrit level was 35.6%. The most common diagnosis among patients was anemia of prematurity.
Conclusions:
It was demonstrated that internationally standardized transfusion guidelines or criteria diverge from the practices carried out in this hospital unit. The indication for transfusion should always be individualized through a comprehensive assessment to avoid negatively influencing clinical outcomes.
Lozano-Pineda, Georgina1,2; Jiménez-González, MarÃa del Carmen1,3; Ovilla-Moreno, Liliana1,4
1 Neonatal Intensive Care Unit, General Hospital No. 1. Tapachula, Chiapas, Mexico.
2 Third-year pediatrics resident.
3 Head of Blood Bank.
4 Attending physician.
To download the complete research, click below:
https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=121308
Join the doctors who get the most relevant medical news, curated by specialty, every week — no spam, unsubscribe anytime.
